128PTislelizumab in combination with chemotherapy for Chinese patients (Pts) with gastric/gastroesophageal junction cancer (GC/GEJC) or esophageal squamous cell carcinoma (ESCC).

Autor:	Bai, Y1 (AUTHOR), Xu, N2 (AUTHOR), Yuan, X3 (AUTHOR), Wang, B4 (AUTHOR), Li, E5 (AUTHOR), Li, X6 (AUTHOR), Li, Y6 (AUTHOR), Wang, X6 (AUTHOR), Yang, S6 (AUTHOR), Xu, J7 (AUTHOR)
Zdroj:	Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu